Dementia News - ScienceDaily
WEBRead the latest medical research on dementia. Causes, symptoms, lowering the risks, care, medications and new treatments for dementia.
Lifestyle changes may slow or improve Alzheimer’s and dementia ... - CNN
WEBJun 7, 2024 · Ten people saw their cognition actually improve, while a blood test found levels of amyloid, a hallmark of Alzheimer’s disease, were retreating, said lead study author Dr. Dean Ornish, a ...
FDA fully approves Leqembi, first drug shown to slow Alzheimer's ...
WEBJul 6, 2023 · Andrew Harnik/AP. The Food and Drug Administration has fully approved the first drug shown to slow down Alzheimer's disease. The action means that Leqembi, whose generic name is lecanemab, should...
New Drug Approved for Early Alzheimer’s - The New York Times
WEBJul 2, 2024 · The Food and Drug Administration on Tuesday approved a new drug for Alzheimer’s disease, the latest in a novel class of treatments that has been greeted with hope, disappointment and...
FDA approves new Alzheimer’s drug that appears to slow disease - NBC News
WEBJan 6, 2023 · Most drugs approved by the FDA for Alzheimer’s are aimed at helping symptoms, not actually slowing the progression of the disease. Friday's announcement comes on the heels of a scathing ...
New Treatment Reverses Alzheimer’s Disease Signs
WEBDec 20, 2023 · PHILADELPHIA – A “chaperone” molecule that slows the formation of certain proteins reversed disease signs, including memory impairment, in a mouse model of Alzheimer’s disease, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
How cognition changes before dementia hits - MIT News
WEBFeb 29, 2024 · Language-processing difficulties are an indicator of amnestic mild cognitive impairment (aMCI), a risk factor for dementia due to Alzheimer’s disease, according to a new study.
News | Alzheimer's Association
WEBAug 22, 2024 · News updates for Alzheimer's and related dementias – find the latest information on treatments, care, research and Alzheimer's Association events.
Start of new era for Alzheimer’s treatment — Harvard Gazette
WEBJun 5, 2023 · Researchers say we appear to be at the start of a new era for Alzheimer’s treatment. Trial results published in January showed that for the first time a drug has been able to slow the cognitive decline characteristic of the disease. The drug, lecanemab, is a monoclonal antibody that works by binding to a key protein linked to the malady ...
HHS Releases National Plan Update Marking Year of Progress on …
WEBDec 12, 2023 · The National Plan is a roadmap of strategies and actions of how HHS and its partners can accelerate research, expand treatments, improve care, support people living with dementia and their caregivers, and encourage action to reduce risk factors.
Skip to content